Table 3 Risk of VTE according to HbA1c in patients with CVD
Characteristics | Number of cases (%) | Number of controls (%) | Unadjusted ORs (95% CI) | Adjusted ORs* (95% CI) |
|---|---|---|---|---|
CVD and risk of VTE | ||||
≤ 6.5% | 670 (33.0) | 2998 (37.9) | 0.99 (0.87–1.13) | 1.01 (0.89–1.15) |
> 6.5–7.0% | 352 (17.3) | 1524 (19.3) | 1 (reference) | 1 (reference) |
> 7.0–7.5% | 307 (15.1) | 1142 (14.4) | 1.19 (1.02–1.39) | 1.14 (0.97–1.34) |
> 7.5–8.0% | 163 (8.0) | 610 (7.7) | 1.18 (0.98–1.43) | 1.13 (0.93–1.38) |
> 8.0–9.0% | 193 (9.5) | 568 (7.2) | 1.49 (1.24–1.78) | 1.39 (1.16–1.68) |
> 9.0% | 201 (9.9) | 624 (7.9) | 1.47 (1.22–1.77) | 1.16 (0.95–1.42) |
No Recording | 147 (7.2) | 450 (5.7) | 1.55 (1.25–1.94) | 1.56 (1.24–1.96) |
HbA1c-Values (last measurement before the index date) and risk of VTE in women | ||||
≤ 6.5% | 377 (34.4) | 1689 (39.2) | 1.04 (0.87–1.23) | 1.07 (0.90–1.28) |
> 6.5–7.0% | 177 (16.2) | 818 (19.0) | 1 (reference) | 1 (reference) |
> 7.0–7.5% | 166 (15.2) | 618 (14.4) | 1.29 (1.04–1.59) | 1.21 (0.96–1.51) |
> 7.5–8.0% | 87 (7.9) | 317 (7.4) | 1.30 (1.00–1.69) | 1.26 (0.95–1.66) |
> 8.0–9.0% | 93 (8.5) | 285 (6.6) | 1.39 (1.08–1.80) | 1.30 (0.99–1.70) |
> 9.0% | 107 (9.8) | 318 (7.4) | 1.64 (1.28–2.12) | 1.27 (0.97–1.68) |
No Recording | 89 (8.1) | 260 (6.0) | 1.80 (1.35–2.41) | 1.83 (1.35–2.46) |
HbA1c-Values (last measurement before the index date) and risk of VTE in men | ||||
≤ 6.5% | 293 (31.3) | 1309 (36.3) | 0.94 (0.78–1.14) | 0.94 (0.78–1.13) |
> 6.5–7.0% | 175 (18.7) | 706 (19.6) | 1 (reference) | 1 (reference) |
> 7.0–7.5% | 141 (15.1) | 524 (14.5) | 1.09 (0.87–1.37) | 1.06 (0.84–1.34) |
> 7.5–8.0% | 76 (8.1) | 293 (8.1) | 1.07 (0.82–1.41) | 0.98 (0.74–1.31) |
> 8.0–9.0% | 100 (10.7) | 283 (7.8) | 1.59 (1.23–2.05) | 1.50 (1.15–1.96) |
> 9.0% | 94 (10.0) | 306 (8.5) | 1.30 (0.99–1.72) | 1.06 (0.79–1.41) |
No Recording | 58 (6.2) | 190 (5.3) | 1.26 (0.90–1.78) | 1.26 (0.88–1.81) |